News
 |
UArizona Health Sciences Expanding Roles for Genetic Counselors in the Era of Precision Medicine Genetic counseling is one of the fastest growing professions in the United States. To meet this growing demand, the University of Arizona Health Sciences opened a graduate program in genetic counseling. |
 |
UArizona Researcher Receives $1.1M to Study Genetic Risk Factors for Type-2 Diabetes and Heart Disease Genetic epidemiologist Yann Klimentidis, PhD, at the UA Mel and Enid Zuckerman College of Public Health received a $1.1 million grant from the National Institutes of Health to study the connection between type-2 diabetes and cardiovascular disease. |
 |
Taking the Fight to the Molecular Level: The Human Genome Is Our Greatest Weapon Dr. Hammer is working with researchers throughout the UA Cancer Center to prioritize a growing list of questions that could be addressed in future MOTB casework. |
 |
Member Spotlight: Qin Chen, PhD Read about the latest publications, achievements and more from the Center's faculty members! |
 |
Literature Review from UA Researchers Provides New Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing Dr. Karnes and his research team summarize evidence from the published literature supporting associations and providing therapeutic recommendations for the use of phenytoin based on CYP2C9 and/or HLA-B genotypes. |
 |
UA Genetic Counseling Graduate Program Gains Accreditation The new UA graduate program is the only genetic counseling graduate program in Arizona and fills a significant gap in genetic counselor training in the Southwestern United States. |
 |
UA Researchers Help Discover Genetic Factor That Can Help or Hurt Risk for Heart Disease Individuals with a particular genetic factor may be more resistant to plaque build-up and have a reduced risk for coronary artery disease. |
 |
Genome Sequencing Project in Critically Ill Infants Featured in the Washington Post The article highlights key work being done as part of the Sanford Children's Genomic Medicine Consortium. |
 |
Academic medical centers as innovation ecosystems to address population –omics challenges in precision medicine While the promise of the Human Genome Project provided significant insights into the structure of the human genome, the complexities of disease at the individual level have made it difficult to utilize –omic information in clinical decision making. |
 |
New Study from UA Researcher Shows Fetal Alcohol Syndrome in the US is More Common than Previously Thought A new study from researchers including TCAG2M's Dr. Gene Hoyme show that the prevalence of fetal alcohol syndrome disorders is 1.1 – 5.0% in four US communities. |
 |
FDA Approval for New Severe Asthma Therapy Advanced by TCAG2M Researcher Clinical trials led by Dr. Eugene Bleecker, Co-Director of the TCAG2M Division of Pharmacogenomics, lead to FDA approval for a therapy to treat severe asthma. |
 |
Dee Quinn Honored at National Society of Genetic Counselors Annual Meeting Dee Quinn, MS, CGC, was awarded the Janus Lectureship at the 2017 Annual Meeting for the National Society of Genetic Counselors. |
 |
Is It Obesity or Lipedema? UA Researcher Receives Grant to Study Genetic Risk Factors A new study looks for genetic risk factors for lipedema, a condition characterized by excessive fat deposits causing enlargement of the buttocks, hips and legs and a relatively small waist circumference. |
 |
TCAG2M Launches Community Engagement Effort with New Series, Genes on Screen The Community Engagement Division of TCAG2M launches a new documentary and panel discussion series, Genes on Screen. |
 |
Advances in Genetic Medicine Make Local Impact A local news story features brothers in Tucson fighting a genetic disease, Spinal Muscular Atrophy, with a newly available medication. |
 |
TCAG2M Welcomes Co-Directors of the Division of Pharmacogenomics TCAG2M welcomes the new co-directors of the Division of Pharmacogenomics, Drs. Deborah Meyers and Eugene Bleecker. |
 |
University of Arizona Health Sciences and Banner Health Awarded NIH Precision Medicine Grant The University of Arizona Health Sciences and Banner Health have been selected as a key member of the National Institute of Health Precision Medicine Initiative Cohort Program, receiving a $4 million grant on July 6, 2016, part of a five-year $43.3 million grant. |
 |
Dr. Kenneth Ramos featured in local news story about National Precision Medicine Initiative |
 |
White House Announcement: UA Health Sciences Commits Biomedical Informatics and Genome Medicine Teams to National Precision Medicine Initiative |
 |
University of Arizona’s BIO5 Institute Announces Collaboration with Johnson & Johnson Innovation to Explore Novel Asthma Solutions |